ABSTRACT
INTRODUCTION
Smooth muscle cells (SMC) comprise the muscle of several tissues and organs including the bladder, abdominal cavity, gastrointestinal tract, respiratory tract and blood vasculature where they provide contractile function and play a critical role in major human diseases including atherosclerosis, hypertension and asthma. 1 As a result SMC are very important for development of cell therapies especially for treatment of cardiovascular disease. Although SMC can be isolated from existing blood vessels the process is invasive, requires major surgery and injures the donor site. In addition, mature SMC have limited proliferative capacity thus necessitating multiple tissue harvests for repeat grafting procedures.
The hair follicle is a very rich source of multipotent adult stem cells and as such it may be an easily accessible, alternative source of autologous SMC. Epidermal stem cells are located in the bulge area of the hair follicle as shown by label retaining assays 2, 3 as well as by transgenic mice designed to express EGFP in that region. 4, 5 In a pioneering study Lako at al. first demonstrated that cells from the dermal papilla or dermal sheath but not from the epidermal compartment of hair follicles could reconstitute multiple lineages of the hematopoietic system in lethally irradiated mice. 6 In the presence of appropriate induction medium, cells form the dermal papilla or dermal sheath were also shown to differentiate toward the adipogenic, osteogenic, chondrogenic and myogenic lineages similar to bone marrow mesenchymal stem cells. 7, 8 Additionally, nestinpositive cells from the skin and hair follicles were shown to express neuronal and glial markers and were able to reconstitute the vasculature upon transplantation. [9] [10] [11] [12] [13] [14] [15] [16] Taken together these data suggest that hair follicles contain multipotent stem cells with the ability to regenerate the epidermis as well as mesenchymal and hematopoietic tissues.
Previous studies reported differentiation of stem cells from bone marrow [17] [18] [19] or cord blood 18 into SMC by supplementing the culture medium with one or more growth factors. Although these methods are straightforward, they can not achieve isolation of a pure population of smooth muscle cells without contamination from fibroblasts or other cells. To address this issue, we proposed a novel method of SMC isolation that relies on expression of a fluorescent marker protein (EGFP) from the smooth muscle alpha-actin (SMαA) promoter. 20 To this end, bone marrow mesenchymal stem cells were transfected with a plasmid encoding for EGFP under the SMαA promoter and were subsequently Based on these studies we hypothesized that we can isolate functional smooth muscle cells from hair follicles by employing SMαA-driven EGFP expression and fluorescence activated cell sorting. Using this strategy we showed that the hair follicle is a rich source of smooth muscle progenitor cells with very high proliferation potential and contractile function. In addition to SMαA, HF-SMPC expressed several markers of SMC lineage including calponin, myosin heavy chain (MHC), smoothelin, SM22 and caldesmon. Clonogenic and long-term growth assays showed that HF-SMPC had much higher proliferation potential than mature V-SMC from newborn animals. Karyotype analysis showed that HF-SMPC were normal with no sign of transformation, suggesting that these cells can be expanded to the numbers necessary for development of cell therapies. Notably, HF-SMPC exhibited ability to generate force as shown by compaction of fibrin hydrogels and contractility in response to vasoactive agonists. Our study suggests that hair follicle may be a readily accessible source of autologous, highly proliferative and functional SMC that can be used for tissue engineering and regenerative medicine.
MATERIALS AND METHODS

Retroviral vector encoding EGFP under the control of SMα α α αA promoter
The rat SMαA promoter was cloned into the promoterless EGFP reporter vector pEGFP-1 (Clontech, Mountain View, CA) as described previously. 20 The SMaA-EGFP sequence from this vector was amplified by high fidelity PCR with forward primer:
CCTCTAGACCACGGTCCTTAAGCATGATA containing the XbaI site (underlined); Ovine vascular smooth muscle cells (V-SMC) from umbilical veins of near-term fetal lambs were isolated as described previously 21 and served as positive controls. 
Histology and immunohistochemistry
Histology and immunostaining were performed as described previously 20, 22 
Transmission electron microscopy (TEM)
Fibrin-based TEV were prepared from V-SMC or HF-SMC. After for two weeks in culture, the tissues were cut into ~1mm 3 pieces and fixed in 2% glutaraldehyde, 0.1M sodium cacodylate, pH 7.2 for 2 hr; then postfixed in 1% osmium tetroxide in 0.1M sodium cacodylate for 1 hr and stored in buffer. Dehydration was accomplished via graded ethanol and acetone prior to embedding in Epon-Araldite resin. Sixty to 100 nm thin sections were cut with a Sorvall MT2 ultramicrotome, mounted on copper mesh grids, and stained with uranyl acetate and lead citrate. The samples were observed and photographed with a Hitachi H500 electron microscope operating at 75KV. Negatives were scanned at 1200 dpi with an Agfa T1200 scanner using IPlab and Adobe Photoshop software, unsharp masked, and resampled to required resolution for publication.
Western blots
Western blots for SMαA, calponin and MHC were performed as described previously.
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Compaction of fibrin hydrogels
Three-dimensional fibrin gels were prepared with HF-SMPC, V-SMC or HaCaT cells.
For each gel, cells (10 6 cells/mL) were resuspended in 200 µL of 12.5U/mL thrombin and mixed with 800 µL of 3.125 mg/mL fibrinogen (BD Biosciences, Franklin Lakes, NJ).
The mixture was allowed to polymerize in a well of a 24-well plate (polymerization time:
~ 15 sec) to form gel with final concentration of fibrinogen and thrombin at 2.5 mg/ml and 2.5 U/ml, respectively. After 1 hr the gels were released from the walls and incubated in DMEM + 10% FBS in the presence or absence of TGF-beta1 (2 ng/mL) as indicated.
Cell culture medium was replenished daily. At the indicated times, the gels were photographed at a fixed distance using a gel documentation imaging system (UVP). The area of each gel was measured using Image J and normalized to the initial area (t=0 hr).
Cylindrical smooth muscle tissue equivalents
Tissue equivalents containing HF-SMPC or V-SMC were prepared as described previously. 20, 21, 23 Briefly, HF-SMPC or V-SMC were suspended in thrombin and mixed with fibrinogen at a ratio of 1:4 yielding fibrin gels with final concentration of fibrinogen and thrombin at 2.5 mg/ml and 2.5 U/ml, respectively. For each tissue, 1 ml of fibrin containing 1x10 6 cells was polymerized around a 6.0 mm mandrel of poly(di-methyl siloxane) placed in the middle of each well. After 1 hr the gels were detached from the walls and incubated in 2 ml of DMEM containing 10% FBS. The next day the medium was supplemented with 2 µg/ml insulin, 2 ng/ml TGF-β1, 300 µM ascorbic acid phosphate and 2 mg/ml ε-amino-n-caproic acid. Thereafter, cell culture medium was replenished every three days.
Contractility and mechanical properties of tissue equivalents
After two weeks in culture, the length and diameter of cylindrical tissue equivalents were measured using an electronic digital caliper. Then the tissues were released from the mandrel and mounted on two stainless hooks in an isolated tissue bath and incubated in Krebs-Ringer solution. The tissues were continuously bubbled with 94% O 2 , 6% CO 2 to obtain a pH of 7.4, a Pco 2 of 38 mmHg, and a Po 2 >500 mm Hg at 37ºC.
Each construct was mounted on stainless steel hooks through the lumen, one was fixed, and the other one was connected to a force transducer. Tissues were equilibrated at a basal tension of 1. 
Statistical analysis
Data were expressed as mean ± standard deviation and statistical significance (defined as p<0.05) was determined using Student's t-test.
RESULTS
Isolation of functional smooth muscle cells from ovine hair follicles
Single hair follicles were released from the dermis by digestion of newborn lamb skin with collagenase. After extensive washes, individual hair follicles were placed each in a well of a 96-well plate to allow for cell migration onto the tissue culture plastic ( Fig   1A) . Cells that originated from the bulge region were identified as epidermal keratinocytes, while cells migrating from the dermal sheath and papilla had the morphological appearance of mesenchymal cells. The wells populated with cells originating from the derma sheath and papilla were selected and the cells pooled and expanded.
To obtain smooth muscle cells from the total population of hair follicle cells, passage four cells were transduced with recombinant retrovirus encoding for green fluorescence protein (EGFP) under the control of the SMαA promoter and EGFP+ cells (~ 2% of total cells) were subsequently sorted using fluorescence activated cell sorting.
These hair follicle derived smooth muscle progenitor cells (HF-SMPC) were cultured for two to three more passages to obtain enough cells and then examined for expression of smooth muscle cell markers.
Specifically, RT-PCR showed that HF-SMPC expressed several smooth muscle cell markers including SMαA, calponin, smoothelin, SM22, caldesmon and myosin heavy chain to similar extent as mature vascular smooth muscle cells (V-SMC) from the umbilical vein of newborn lambs (Fig. 1B) . Western blots (Fig. 1C) and alpha-actinin in HF-SMPC and V-SMC (Fig. 1D) . Interestingly alpha-actinin was organized in Z-bodies as previously described for SMC and immature cardiomyocytes.
24-
26 MHC could not be detected due to lack of availability of anti-ovine antibody that was appropriate for flow cytometry or immunocytochemistry.
HF-SMPC exhibited high clonogenic potential
Next we examined the proliferation ability of HF-SMPC using both clonogenic and long-term proliferation assays. For clonal analysis, HF-SMPC or V-SMC were seeded at 5 cells per cm 2 and cultured for 10-12 days until large cell colonies were visible.
HF-SMPC formed significantly higher number of colonies than V-SMC (Fig. 2A) . The fraction of HF-SMPC that formed colonies larger than 2mm in diameter was 26.7 ± 5.9 %.
In contrast, only 3.7 ± 0.6 % of V-SMC were able of forming 2mm or larger colonies.
The distribution of colony size for both cell types is shown in Fig. 2B . Proliferation assays showed that HF-SMPC could be expanded a million fold over a period of 6 weeks in culture, while V-SMC expanded only by a thousand-fold (Fig. 2C) . Despite the high proliferation rate, karyotype based on DAPI banding showed that HF-SMPC were normal with no sign of transformation (Fig. 2D) .
HF-SMPC generated force and compacted fibrin hydrogels
Next we examined the ability of HF-SMPC to generate force and compact three dimensional fibrin matrix. To this end, HF-SMPC or V-SMC (10 6 cells/ml) were embedded in fibrin hydrogels prepared with 2.5mg/ml fibrinogen (FBG) and 2.5U/ml thrombin. Each cell-containing gel was polymerized into a well of a 24-well plate. An hour after gelation the hydrogels were released from the walls and compaction was monitored by measuring the area of each disk at the indicted times. As shown in Fig. 3A , the rate and maximum extent of compaction were similar for both cell types, suggesting that HF-SMPC possessed the contractile machinery to generate mechanical force and compact fibrin hydrogels. In contrast, HaCaT cells failed to compact the fibrin matrix (Fig. 3B) .
HF-SMPC displayed significant contractility
The defining property of mature V-SMC is their ability to contract and generate force in response to vasoactive agonists. To examine whether HF-SMPC exhibited functional properties of mature V-SMC, we measured the isometric tension generated by cylindrical rings of fibrin-based tissue constructs containing HF-SMPC or V-SMC, as we reported previously. 20, 21, 23 To this end, cylindrical tissue equivalents were cultured around 4-mm diameter mandrels for two weeks. At that time, HF-SMPC and V-SMC tissues compacted significantly reaching wall thickness of 0.61±0.06 mm (n=4) and 0.65±0.03 mm (n=4),
respectively. Both cell types appeared to be uniformly distributed in the hydrogel (H&E) and stained positive for SMαA and calponin (Fig. 4A-C) . In addition, transmission electron microscopy showed that that both V-SMC and HF-SMPC in fibrin hydrogels appeared elongated and contained numerous microfilaments (7-10 nm in diameter) that were detected underneath the plasma membrane and organized parallel to the long axis of the cell (Fig. 4D) .
Tissue equivalents prepared with HF-SMPC and V-SMC exhibited similar ultimate tensile strength (HF-SMPC: 252.7±63.4 kPa, n=4; V-SMC: 251.1±89 kPa, n=4) and elasticity (HF-SMPC: 40±5.2 kPa, n=4; V-SMC: 46.3±8.9 kPa, n=4), suggesting that HF-SMPC could remodel the fibrin matrix to a similar extent as V-SMC. We also measured the isometric tension of tissue equivalents in response to KCl (118 mM) or U46619 (10 -6 M). Notably, HF-SMPC containing tissue equivalents (n=23) showed similar vasoconstriction to all three agonists as V-SMC containing tissues (n=23) (Fig.   5A, B) . These results strongly suggested that HF-SMPC had developed active pathways of receptor and non-receptor mediated contraction.
TGF-beta1 increased expression of MHC and compaction of fibrin hydrogels
TGF-beta1 is known to affect V-SMC differentiation and contractility. 27 Therefore, we examined whether TGF-beta1 had a similar effect on differentiation of HF-SMPC. Western blotting showed that similar to V-SMC, HF-SMPC expressed the late differentiation marker MHC, which was further increased by treatment with TGF-beta1 (Fig. 6A) .
We also examined whether TGF-beta1 affected the functional properties of HF-SMPC by measuring its effect on compaction of fibrin hydrogels. Indeed, TGF-beta1 increased compaction of fibrin hydrogels containing V-SMC or HF-SMPC (Fig. 6B) ,
suggesting that similar to V-SMC, TGF-beta1 increased the ability of HF-SMPC to generate force.
DISCUSSION
Despite significant progress toward development of biomaterials and methods to cultivate 3D vascular grafts, cell sourcing remains a major problem. Recent studies showed that function of V-SMC from different species may behave differently and that vascular constructs made from human V-SMC exhibited significantly lower mechanical properties as compared to those from rat cells. [28] [29] [30] In addition, adult somatic cells were shown to exhibit limited replicative capacity especially when they originated from older donors, the population most likely to suffer from cardiovascular disease. 31, 32 Therefore, an easily accessible, autologous source of progenitor vascular cells is necessary to enable development of cell therapies for cardiovascular disease.
Interestingly, HF-SMPC appeared in culture of HF cells that were grown in the presence of serum but with no additional differentiation promoting factors. HF-SMPC cells appeared as early as passage four as evidenced by the activity of the alpha-actin promoter. Using the same medium previous studies showed that rat hair follicles cells were able to differentiate toward bone, cartilage and fat cells, similar to bone marrow derived mesenchymal stem cells. 7, 8 In the presence of embryonic stem cell medium containing knock-out serum and basic fibroblast growth factor, human hair follicle derived cells remained undifferentiated for several passages while maintaining the ability to differentiate towards melanocytic, myogenic and neuronal lineages. 33 It would be interesting to examine the effect of embryonic stem cell medium in preventing differentiation and maintaining the pluripotency of ovine HF cells that were used in this study.
Although several studies used growth factor cocktails to differentiate cells from various sources into mature SMC, 17, 18, [34] [35] [36] in no case has a purified population of contractile SMC been derived. In contrast, our work demonstrated that use of the SMαA promoter to drive expression of EGFP could successfully purify contractile SMC from bone marrow 20 and in the present study from hair follicle cells. A previous study employed the SM22 promoter to isolate SMC from bone marrow mononuclear cells. 37 Selected clones expressed SMC markers only after long-term drug selection, suggesting that only a small fraction of cells with active SM22 promoter expressed SMC markers. In addition, functional properties of these cells such as force generation or contractility were not investigated. More recently, MHC and SMαA promoters were employed to drive expression of puromycin-N-acetyltransferase as a way to purify SMC from human embryonic stem cells (hESC). 38 In agreement with our study, the SMαA promoter resulted in contractile SMC that expressed multiple SMC differentiation specific markers.
Surprisingly, the MHC promoter resulted in mixed population of cells with regards to expression of some SMC markers including SMαA. Collectively these studies suggest that the SMαA promoter may provide a convenient and efficient way to isolate functional SMC from embryonic or adult stem cell sources.
Our results are in agreement with a recent study from our laboratory that used the SMαA promoter and fluorescence activated cell sorting to isolate smooth muscle progenitor cells from bone marrow (BM-SMPC). 20 Similar to HF-SMPC, BM-SMPC were highly proliferative; expressed several SMC markers at the mRNA and protein levels; and displayed receptor and non-receptor mediated contractility. Notably, vascular grafts from BM-SMPC could withstand interpositional implantation into the jugular veins of lambs. Within five weeks post-implantation, BM-SMPC remodeled the fibrin matrix and synthesized collagen and elastin. In contrast to V-SMC from umbilical veins, BM-SMPC organized elastin into fibers, an important characteristic of native vessels that has been difficult to recapitulate in engineered tissues. 30 To establish the therapeutic potential of HF-SMPC, we plan to employ the same animal model to examine implantability and extracellular matrix remodeling of HF-SMPC based vascular grafts.
The quintessential property of SMC is their ability to generate force in response to vasoactive agonists. Interestingly, when HF-SMPC were embedded in fibrin hydrogels they compacted the matrix to similar extent as V-SMC, suggesting that these cells had developed the ability to generate force. HF-SMPC or V-SMC were serum-starved overnight and then treated with TGF-beta1 (2 ng/ml). The next day cells were lysed and MHC was detected using western blot. Total Erk1/2 served as loading control. Lane intensity was determined using Kodak gel documentation software and normalized to Erk1/2 loading control (Ratio). Values of the ratio are the mean ± SE of three independent experiments. (B) HF-SMPC or V-SMC were embedded in fibrin and cultured for 24 hr in the absence or presence of TGF-beta1 (2 ng/ml). The area of each gel was measured immediately after it was released from the wall (t=0) and 24 hr later using Image J software. The ratio of the area at t=24 hr over the initial area was plotted as mean ± SD of triplicate samples in a representative experiment (HF-SMPC, n=3; V-SMC, n=2).
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